• Gan To Kagaku Ryoho · Jun 1992

    [Radiotherapy in the conservative management of breast cancer].

    • T Yamashita, M Nakazawa, M Soukawa, S Hayashi, Y Sunagawa, and K Sekiguchi.
    • Dept. of Radiation Oncology, Cancer Institute Hospital, Tokyo, Japan.
    • Gan To Kagaku Ryoho. 1992 Jun 1; 19 (6): 763-8.

    AbstractBreast conserving therapy is now considered standard treatment in patients with early breast cancer, and it yields equal local control and survival equal to those of radical mastectomy, in Europe and the United States. After many reports from western countries, Japanese surgeons started conservative treatment for early breast cancer. The aim of radiotherapy is to eradicate residual tumor after quadrantectomy or lumpectomy. Indication for this management by Fujio Kasumi at the Cancer Institute Hospital is T1, N0, M0. We reported here the method of radiotherapy, that is energy of photon, treatment field and total dose, which are discussed by the study group of the Japanese Society for Therapeutic Radiology and Oncology.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.